Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources

Japanese Journal of Clinical Oncology

Volumn 36, Issue 10, 2006, Pages 613-619

  Rastogi, Madhup ^a   Bhatt, Madanial ^a   Chufal, Kundan ^b   Srivastava, Madhu ^a   Pant, Mohan ^a   Srivastava, Kirti ^a   Mehrotra, Sanjay ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Batra Hospital India   (India)

Author keywords

Chemotherapy; Craniofacial surgical resection; Esthesioneuroblastoma; Non craniofacial surgical resection; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; ESTHESIONEUROBLASTOMA; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HUMAN; INDIA; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NOSE NEOPLASMS; REGISTRIES; SURVIVAL RATE; VINCRISTINE;

EID: 33750683970     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl086     Document Type: Article

References (30)

1. McCormack LJ, Harris HE. Neurogenic tumors of the nasal fossa. JAMA 1955;157:318-21.
2. Spiro JD, Soo KC, Spiro RH. Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck 1995;17:114-18.
3. Svane-Knudsen V, Jorgensen KE, Hansen O, Lindgren A, Marker P. Cancer of the nasal cavity and paranasal sinuses: A series of 115 patients. Rhinology 1998;36:12-14.
4. Skarsgard DP, Groome PA, Mackillop WJ, Zhou S, Rothwell D, Dixon PF, et al. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 2000;88:1728-38.
5. Broich G, Pagliari A, Ottavkiani F. Esthesioneuroblastoma: A general review of the cases published since the discovery of tumor in 1924. Anticancer Res 1997;17:2683-706.
6. Kadish S, Goodman M. Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976;37:1571-67.
7. Jekunen AP, Kairemo KJ, Lehtonen HP, Kajanti MJ. Treatment of olfactory neuroblastoma. A report of 11 cases. Am J Clin Oncol 1996;19:375-8.
8. Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, Marandas P, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998;112:628-33.
9. Levine PA, McLean WC, Cantrell RW. Aesthesioneuroblastoma: The University of Virginia experience 1960-1985. Laryngoscope 1986;96: 742-6.
10. Biller HF, Lawson W, Sachdev VP,Som P. Esthesioneuroblasoma: Surgical treatment without radiation. Laryngoscope 1990;100:1199-201.
11. Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, et al. Esthesioneuroblastoma. Long-term outcome and patterns of failure - the University of Virginia experience. Cancer 1994;73:2556-62.
12. Dulguerov P, Calcaterra T. Esthesioneuroblastoma. The UCLA experience 1970-1990. Laryngoscope 1992;102:843-9.
13. Foote RL, Morite A, Ebersold MJ, Olsen KD, Lewis JE, Quast LM, et al. Esthesioneuroblastoma: The role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:835-42.
14. Irish J, Dasgupta R,Freeman J, Gullane P, Gentili F, Brown D, et al. Outcome and analysis of the surgical management of esthesioneuroblasoma. J Otolaryngol 1997;26:1-7.
15. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: Prognosis and management. Neurosurgery 1993;32:706-14. discussion 714-15.
16. Polin RS, Sheehan JP, Chenelle AG, Munoz E, Larner J, Phillips CD, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: The University of Virginia experience. Neurosurgery 1998;42:1029-37.
17. Shah JP, Feghali J. Esthesioneuroblastoma. CA Cancer J Clin 1998;33:154-9.
18. Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg 1997;123: 34-40.
19. Chapman P, Carter RL, Clifford P. The diagnosis and surgical management of olfactory neuroblastoma: The role of craniofacial resection. J Laryngol Otol 1981;95:785-99.
20. Heros DO, Hoch berg FH. Treatment of esthesioneuroblastoma with chemotherapy: A report of two cases. J Neurooncol 1988;6:141-5.
21. McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advance esthesioneuroblastoma: The Mayo Clinci experience. Neurosurgery 1998;42:1023-7.
22. O'Conor GT Jr, Drake CR, Johns ME, Cail WS, Winn HR, Niskanen E. Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report. Cancer 1985;55:347-9.
23. Shah JP, Galicich JH. Esthesioneuroblastoma. Treatment by combined craniofacial resection. NY State J Med 1979;79:84-6.
24. Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: A comparison of two treatment eras. Int J RAdiat Oncol Biol Phys 1988;15:581-90.
25. Walters TR, Pushparaj N, Ghander AZ. Olfactory neuroblastoma. Response to combination chemotherapy. Arch Otolaryngol 1980; 106:242-3.
26. Weiden PL, Yarington CT Jr. Richardson RG. Olfactory neuroblastoma. Chemotherapy and radiotherapy for extensive disease. Arch Otolaryngol 1984;110:759-60.
27. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer 1979;44:1087-94.
28. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: The John Hopkins experience. Head Neck 2000;22:550-8.
29. Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, et al. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 2004;101:2257-60.
30. Mishima Y, Nagasaki E, Terui Y, Irie T, Takahashi S, Ito Yoshinori, et al. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adult with esthesioneuroblastoma. Cancer 2004;101:1437-44.